FDA Inspection 1312682 — Baylor Scott and White McLane Children's Medical Center
The FDA completed an inspection of Baylor Scott and White McLane Children's Medical Center on April 7, 2026 in Temple, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 7, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Temple, TX (United States)